Reduced-intensity allografting in patients with therapy-related myeloid neoplasms and active primary malignancies (Q57636771)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21860429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Reduced-intensity allografting in patients with therapy-related myeloid neoplasms and active primary malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21860429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21860429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

W Zinke-Cerwenka

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21860429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

A Valentin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21860429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

U Posch

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21860429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

C Beham-Schmid

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21860429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

A Groselj-Strele

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21860429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

W Linkesch

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21860429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

A Wölfler

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21860429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

English

0 references

publication date

22 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21860429%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

11 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21860429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21860429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21860429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

1540-1544

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21860429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported i

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

NPM1 mutations in therapy-related acute myeloid leukemia with uncharacteristic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

Therapy-related myeloid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

Outcome of hematopoietic stem cell transplantation for pediatric patients with therapy-related acute myeloid leukemia or myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

Reduced-intensity conditioning transplantation in myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

Cumulative incidence in competing risks data and competing risks regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

Chronic but not acute graft-versus-host disease improves outcome in multiple myeloma patients after non-myeloablative allogeneic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

Hematopoietic stem cell transplantation for multiple myeloma beyond 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

Reduced intensity versus full myeloablative stem cell transplant for advanced CLL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

The allogeneic graft-versus-cancer effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

Graft-vs-tumor effect in patients with advanced nasopharyngeal cancer treated with nonmyeloablative allogeneic PBSC transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

Prognosis in therapy-related acute myeloid leukemia and impact of karyotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

7 January 2021

Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

7 January 2021

Allogeneic Bone Marrow Transplantation for Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Long-Term Study of 70 Patients—Report of the French Society of Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

7 January 2021

Impact of intensity of conditioning therapy in patients aged 40-60 years with AML/myelodysplastic syndrome undergoing allogeneic transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

7 January 2021

Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

7 January 2021

Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.165

7 January 2021

Identifiers

DOI

10.1038/BMT.2011.165

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21860429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference